Subcutaneous patient-controlled analgesia in palliative care.

J Pain Palliat Care Pharmacother

Jayamangala Sampath Kondasinghe, MBBS, FRACP, FAChPM, is with the Palliative Care Specialist, Silverchain Palliative Care Service, Osborne Park, Western Australia. Penelope Helen Rose Tuffin, B. Pharmacy, is with the Palliative Care Pharmacist, Fiona Stanley Hospital, Murdoch, Western Australia. Fiona Joy Findlay, MbChB, FRACP, FAChPM, is with the Palliative Care Specialist, Silverchain Palliative care Service, Osborne Park, Western Australia.

Published: September 2021

AI Article Synopsis

  • SCPCA is an often overlooked pain management technique in palliative care.
  • It is beneficial for patients who can't effectively use traditional oral pain meds or those facing challenges accessing healthcare.
  • This method can offer a safe and effective alternative for managing pain in these specific patient groups.

Article Abstract

Subcutaneous patient-controlled analgesia (SCPCA) is an underutilized method of pain management in palliative care patients. In a select group of patients, including patients in whom enteral analgesia is ineffective or undeliverable, and in patients with limited access to healthcare due to geographical or other logistic issues, SCPCA can provide an effective and safe alternative.

Download full-text PDF

Source
http://dx.doi.org/10.1080/15360288.2021.1920546DOI Listing

Publication Analysis

Top Keywords

subcutaneous patient-controlled
8
patient-controlled analgesia
8
palliative care
8
analgesia palliative
4
care subcutaneous
4
analgesia scpca
4
scpca underutilized
4
underutilized method
4
method pain
4
pain management
4

Similar Publications

[Treatment of cancer-related pain-From pharmacotherapy to invasive procedures].

Anaesthesiologie

December 2024

Sektion Schmerzmedizin, Klinik für Anästhesiologie, Medizinische Fakultät Heidelberg, Universität Heidelberg, Heidelberg, Deutschland.

Depending on the stage of the tumor up to 80% of the patients suffer from cancer-related pain but treatment is often inadequate. Multiple causes can trigger pain and these can be due to the tumor itself, its secondary consequences but also treatment related. A differentiated assessment and individually tailored treatment of cancer-related pain not only improve the quality of life but also reduce the risk of pain chronification.

View Article and Find Full Text PDF

Background: Studies have shown that oral oxycontin tablets can be used for opioid titration. The European Society for Medical Oncology (ESMO) guidelines for adult cancer pain recommend opioid titration through the parenteral route, usually the intravenous or subcutaneous route. Patient-controlled subcutaneous analgesia (PCSA) with hydromorphone needs further evaluation for opioid titration.

View Article and Find Full Text PDF

Objective: Postoperative pain is a major issue with subcutaneous implantable cardioverter defibrillators (S-ICD). In 2020, we introduced intravenous patient-controlled analgesia (IV-PCA) in addition to the conventional, request-based analgesia for postoperative pain control in S-ICD. To determine the effect and safety, we quantitatively assessed the effect of IV-PCA after S-ICD surgery over conventional methods.

View Article and Find Full Text PDF

Background: Postoperative pain management following minimally invasive repair of pectus excavatum (MIRPE) remains a critical concern due to severe post-procedural pain. Promising results have been reported for cryoanalgesia following MIRPE; however, its invasiveness, single-lung ventilation, and additional instrumentation requirements remain obstacles. Serratus anterior plane block (SAPB) is a regional block technique capable of covering the anterior chest wall at the T2-9 levels, which are affected by MIRPE.

View Article and Find Full Text PDF

Subcutaneous Patient-Controlled Analgesia in Home-Based Palliative Care: "".

J Pain Palliat Care Pharmacother

June 2024

, Equipa Comunitária de Suporte em Cuidados Paliativos de Sintra, Rio de Mouro, Portugal.

Subcutaneous patient-controlled analgesia (SCPCA) in home-based palliative care is a potentially valuable option for providing effective pain relief to some patients, particularly when conventional analgesic approaches prove ineffective or are refused. Our case report illustrates the use of SPCA for the management of breakthrough pain in a patient receiving palliative care at home with no improvement after multiple previous treatments. SCPCA was found to be safe and successful.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!